Healthier Choics Financials

HCMC

FY2025 annual

Revenue $3K +494.6% YoY

Net Income -$7.0M YoY not available

EPS (Diluted) Not reported for FY2025

Free Cash Flow Not reported for FY2025

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 19, 2026 Currency USD FYE December

Healthier Choics (HCMC) reported $3K in revenue for fiscal year 2025, up 494.6% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HCMC FY2025 2026-08-29

External financing is offsetting recurring operating cash use while liabilities exceed assets and equity remains negative.

In FY2025, operating cash flow was -$3.9M while financing provided $3.4M, indicating that ongoing operations were not self-funding and outside capital largely bridged the gap. Shares outstanding rose from 481.3M to 527.2M, consistent with financing needs being supported partly through a larger equity base; reported liquidity equaled 3.5 months of the latest annual operating outflow.

A 0.8x current ratio means current liabilities exceeded current assets in FY2025, creating short-term balance-sheet tightness. Total liabilities of $2.7M exceeded assets of $1.5M, leaving negative equity rather than merely elevated debt.

Between FY2021 and FY2022, revenue more than doubled while gross margin compressed from 39.7% to 34.9%; the added volume therefore came with weaker unit economics, not clear evidence of fixed-cost absorption. Operating cash flow remained negative in both years, showing that reported growth did not translate into internally generated cash.

Financial Health Signals

Financial health score not available

Healthier Choics does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-82.56

Healthier Choics scores -82.56, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($52.7M) relative to total liabilities ($2.7M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

4/7

Healthier Choics passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 3 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality No Cash Backing

N/A

Healthier Choics reported a net loss of $7.0M while operations used $3.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Healthier Choics reported an operating loss of $7.0M against $35K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3K

YoY+494.6%

5Y CAGR-81.5%

10Y CAGR-52.6%

Healthier Choics generated $3K in revenue in fiscal year 2025. This represents an increase of 494.6% from the prior year.

EBITDA

-$7.0M

YoY+17.2%

Healthier Choics's EBITDA was -$7.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 17.2% from the prior year.

Net Income

-$7.0M

Healthier Choics reported -$7.0M in net income in fiscal year 2025.

EPS (Diluted)

Not reported for fiscal year 2025.

Cash & Balance Sheet

Cash & Debt

$1.1M

YoY-4.4%

5Y CAGR+4.3%

10Y CAGR-27.2%

Healthier Choics held $1.1M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding

527.16B

YoY+9.5%

5Y CAGR+11.2%

Healthier Choics had 527.16B shares outstanding in fiscal year 2025. This represents an increase of 9.5% from the prior year.

Free Cash Flow

Not reported for fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Operating Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Return on Equity

Not reported for fiscal year 2025.

Capital Allocation

None of these metrics is reported for fiscal year 2025.

HCMC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

HCMC quarterly income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	N/A	$3K+494.6%	$501-18.8%	$617-100.0%	$29.3M+119.7%	$13.3M-4.3%	$13.9M-7.9%	$15.1M+3.2%	$14.6M+13.1%	$12.9M+22.6%	$10.6M+101.1%	$5.3M-65.6%	$15.3M-41.2%	$26.0M+21.7%	$21.4M+33.6%	$16.0M
Cost of Revenue	N/A	$31K-53.7%	$67K+8388.7%	$787	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$14.5M-11.1%	$16.3M+23.3%	$13.2M+96.4%	$6.7M
Gross Profit	N/A	-$28K+57.9%	-$66K-38902.9%	-$170-100.0%	$10.2M+93.2%	$5.3M-8.4%	$5.8M-10.9%	$6.5M-9.5%	$7.2M+14.3%	$6.3M+19.7%	$5.2M+69.9%	$3.1M+293.6%	$783K-91.9%	$9.7M+19.2%	$8.1M-12.1%	$9.2M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$312K+79.3%	$174K+9.4%	$159K	N/A
SG&A Expenses	N/A	N/A	$1.0M-96.9%	$32.2M+70.7%	$18.9M+88.2%	$10.0M+13.4%	$8.8M-15.1%	$10.4M+4.7%	$10.0M-39.5%	$16.4M+69.5%	$9.7M+3.5%	$9.4M-15.7%	$11.1M+72.1%	$6.5M-5.8%	$6.9M+65.1%	$4.2M
Operating Income	-$3.6M	-$7.0M+17.3%	-$8.5M-14.1%	-$7.5M+13.9%	-$8.7M-82.5%	-$4.7M-37.5%	-$3.4M+21.9%	-$4.4M-48.0%	-$3.0M+71.0%	-$10.3M-16.1%	-$8.9M+60.7%	-$22.5M-77.3%	-$12.7M-1424.7%	$960K+141.8%	-$2.3M-303.3%	$1.1M
Interest Expense	$15K	$35K-72.4%	$126K-69.4%	$412K+103.1%	$203K+210.4%	$65K-76.1%	$273K+667.4%	$36K+298.5%	$9K+62.0%	$6K-64.2%	$15K-85.8%	$108K-43.8%	$193K-49.8%	$384K+329.8%	$89K	N/A
Income Tax	N/A	N/A	N/A	N/A	$0	$0	$0	$0	$0	N/A	N/A	N/A	$767K+246.2%	-$525K-12.6%	-$466K-211.8%	$417K
Net Income	-$3.6M	-$7.0M	N/A	-$18.5M-156.1%	-$7.2M-78.8%	-$4.0M-8.5%	-$3.7M-33.0%	-$2.8M+78.7%	-$13.2M-33.3%	-$9.9M-192.4%	$10.7M+493.3%	$1.8M+113.0%	-$13.9M-1828.6%	$801K+141.7%	-$1.9M-369.3%	$713K
EPS (Diluted)	—	N/A	N/A	$0.00	$0.00	$0.00	$0.00	N/A	N/A	N/A	N/A	N/A	-$0.84	$0.06	-$0.16	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	N/A	N/A	$0-100.0%	$199-80.1%	$1K-99.9%	$1.8M+1140925.6%	$156+200.0%	$52
Cost of Revenue	N/A	N/A	N/A	N/A	$24K-98.4%	$1.5M+2118.7%	$67K+444013.3%	$15
Gross Profit	N/A	N/A	-$6K-2918.1%	$199+100.9%	-$23K-107.6%	$302K+554.4%	-$66K-179724.3%	$37
Operating Income	$85K+110.5%	-$807K-4.1%	-$775K+62.8%	-$2.1M-4.1%	-$2.0M+99.9%	-$2.2B-98913.0%	-$2.2M-2.2%	-$2.1M
Interest Expense	-$9K-227.8%	$7K-14.5%	$9K-3.6%	$9K+1.6%	$9K-99.9%	$8.5M+75729.6%	$11K-25.4%	$15K
Net Income	$75K+109.6%	-$787K-2.7%	-$766K+63.1%	-$2.1M-4.2%	-$2.0M+99.9%	-$2.2B	N/A	-$4.3M

Not reported in any period shown, so not listed: R&D Expenses, SG&A Expenses, Income Tax, EPS (Diluted).

HCMC Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

HCMC quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$1.5M-33.9%	$2.2M-92.8%	$31.0M-44.0%	$55.3M+60.4%	$34.4M+190.1%	$11.9M-15.2%	$14.0M-7.7%	$15.2M+29.7%	$11.7M-32.1%	$17.2M-49.7%	$34.2M+594.9%	$4.9M-64.7%	$14.0M+217.4%	$4.4M-6.4%	$4.7M
Current Assets	$1.3M-31.3%	$1.9M-83.4%	$11.7M-61.3%	$30.3M+5.3%	$28.8M+856.8%	$3.0M-17.4%	$3.6M-61.7%	$9.5M+6.1%	$9.0M-37.5%	$14.3M-51.6%	$29.6M+616.7%	$4.1M-70.3%	$13.9M+217.9%	$4.4M-6.4%	$4.7M
Cash & Equivalents	$1.1M-4.4%	$1.2M-67.4%	$3.7M-85.2%	$24.7M-6.8%	$26.5M+2763.0%	$925K-39.3%	$1.5M-78.4%	$7.1M-10.4%	$7.9M-41.0%	$13.4M-50.9%	$27.2M+5675.8%	$471K-92.8%	$6.6M+3624.4%	$176K-50.5%	$356K
Inventory	$36K-10.7%	$40K-39.3%	$67K-98.3%	$3.8M+150.9%	$1.5M-13.0%	$1.7M-0.4%	$1.8M-5.8%	$1.9M+116.4%	$862K+15.1%	$749K-20.9%	$947K-53.8%	$2.0M-38.3%	$3.3M+98.9%	$1.7M-25.3%	$2.2M
Accounts Receivable	$199	N/A	$128K+129.6%	$56K+96.0%	$28K+20.3%	$24K-63.8%	$65K-0.8%	$66K-12.7%	$76K+192.9%	$26K-75.7%	$106K-55.8%	$240K-86.7%	$1.8M+140.8%	$749K+19.9%	$625K
Goodwill	N/A	N/A	N/A	$5.7M+527.4%	$916K0.0%	$916K-4.2%	$956K-33.5%	$1.4M+198.6%	$481K0.0%	$481K-84.9%	$3.2M	N/A	N/A	N/A	N/A
Total Liabilities	$2.7M-28.6%	$3.8M-83.6%	$23.1M-34.1%	$35.0M+572.7%	$5.2M-45.8%	$9.6M+18.7%	$8.1M+20.1%	$6.7M-40.1%	$11.3M-23.8%	$14.8M-68.4%	$46.8M+1037.6%	$4.1M+86.2%	$2.2M-54.7%	$4.9M+47.4%	$3.3M
Current Liabilities	$1.6M-40.4%	$2.7M-78.2%	$12.2M+23.5%	$9.9M+292.5%	$2.5M-55.4%	$5.7M+53.2%	$3.7M-34.3%	$5.6M-50.1%	$11.2M-23.9%	$14.8M-68.4%	$46.8M+1070.1%	$4.0M+80.8%	$2.2M-45.2%	$4.0M+21.9%	$3.3M
Long-Term Debt	N/A	N/A	$2.4M+1.1%	$2.4M+291686.6%	$815-100.0%	$4.9M	N/A	$1.4M+13285.6%	$10K	N/A	N/A	N/A	N/A	$846K	N/A
Total Equity	-$1.2M+21.0%	-$1.6M-123.1%	$6.8M-66.6%	$20.2M-30.9%	$29.2M+1195.0%	$2.3M-61.8%	$5.9M-30.0%	$8.4M+1796.6%	$444K-82.3%	$2.5M+119.9%	-$12.6M-1650.1%	$812K-93.1%	$11.8M+2530.8%	-$483K-134.9%	$1.4M
Retained Earnings	-$82.1M-9.4%	-$75.0M-20.8%	-$62.1M-42.4%	-$43.6M-19.8%	-$36.4M-12.5%	-$32.4M-13.0%	-$28.6M-11.3%	-$25.7M-104.7%	-$12.6M-357.7%	-$2.7M+79.6%	-$13.4M+11.8%	-$15.2M-1004.0%	-$1.4M+36.7%	-$2.2M-738.7%	-$260K

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$1.5M+4.2%	$1.4M-2.3%	$1.5M-3.8%	$1.5M-0.8%	$1.5M-99.9%	$1.7B+75227.2%	$2.2M-41.3%	$3.8M
Current Assets	$1.4M+5.5%	$1.3M-1.5%	$1.3M+1.7%	$1.3M+0.1%	$1.3M-99.9%	$1.4B+73676.9%	$1.9M-42.5%	$3.4M
Cash & Equivalents	$1.2M+5.2%	$1.1M-0.3%	$1.1M+1.7%	$1.1M+0.2%	$1.1M-99.9%	$1.2B+98389.7%	$1.2M-52.9%	$2.5M
Inventory	$37K0.0%	$37K+1.7%	$36K-5.0%	$38K+18.0%	$32K-99.9%	$39.1M+96518.9%	$40K-39.2%	$67K
Accounts Receivable	$1990.0%	$1990.0%	$1990.0%	$199	N/A	N/A	N/A	N/A
Total Liabilities	$3.2M-0.7%	$3.3M+20.5%	$2.7M-54.8%	$6.0M+18.7%	$5.0M-99.9%	$4.3B+113472.1%	$3.8M-12.2%	$4.3M
Current Liabilities	$2.1M-1.1%	$2.1M+34.8%	$1.6M-67.3%	$4.9M+24.0%	$3.9M-99.9%	$3.2B+119158.4%	$2.7M-16.4%	$3.2M
Total Equity	-$1.7M+4.6%	-$1.8M-47.6%	-$1.2M+72.2%	-$4.4M-27.3%	-$3.5M+99.9%	-$2.6B-167868.3%	-$1.6M-200.1%	-$520K
Retained Earnings	-$82.8M+0.1%	-$82.8M-1.0%	-$82.1M-0.9%	-$81.3M-2.6%	-$79.2M+99.9%	-$77.2B-102810.2%	-$75.0M-3.0%	-$72.9M

Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.

HCMC Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

HCMC quarterly cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	-$2.5M	-$3.9M-6.2%	-$3.7M+22.9%	-$4.7M-22.6%	-$3.9M-9.6%	-$3.5M-54.6%	-$2.3M+35.5%	-$3.5M-2364.2%	-$143K+94.9%	-$2.8M+61.4%	-$7.3M+23.0%	-$9.5M-51.1%	-$6.3M-52.7%	-$4.1M-303.6%	-$1.0M-415.8%	$323K
Capital Expenditures	N/A	N/A	$47K-74.4%	$184K-61.7%	$481K+752.4%	$56K+128.8%	$25K-25.0%	$33K-56.4%	$75K-47.3%	$143K+464.8%	$25K-87.0%	$195K-65.2%	$560K+3691.9%	-$15K+58.6%	$9K-71.3%	$32K
Free Cash Flow	N/A	N/A	-$3.7M+24.8%	-$4.9M-13.3%	-$4.3M-21.3%	-$3.6M-55.4%	-$2.3M+35.4%	-$3.6M-1530.7%	-$219K+92.6%	-$3.0M+59.6%	-$7.3M+24.3%	-$9.7M-41.6%	-$6.9M-65.7%	-$4.1M-301.4%	-$1.0M-454.3%	$291K
Investing Cash Flow	N/A	N/A	-$4.9M-540.0%	-$769K+92.8%	-$10.7M-12183.7%	-$87K-16.1%	-$75K-159.3%	$127K+103.2%	-$4.0M-1986.0%	-$193K+93.9%	-$3.2M-303.2%	-$790K+26.6%	-$1.1M-7190.8%	-$15K-58.6%	-$9K+71.3%	-$32K
Financing Cash Flow	$2.6M	$3.4M-28.0%	$4.7M+134.6%	-$13.5M-206.0%	$12.8M-53.0%	$27.2M+1447.3%	$1.8M+1479.7%	-$127K-103.8%	$3.3M+235.6%	-$2.5M+26.3%	-$3.3M-109.0%	$37.0M+2817.8%	$1.3M-87.9%	$10.5M+1138.7%	$850K	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$12K+98.0%	-$609K+26.0%	-$823K+22.8%	-$1.1M-5.8%	-$1.0M+99.9%	-$984.6M-60585.7%	-$1.6M-470.2%	$438K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	-$1
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	-$1.6M-470.2%	$438K
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	$0+100.0%	-$4.8M
Financing Cash Flow	$71K-88.2%	$606K-28.0%	$842K-21.1%	$1.1M+12.1%	$952K-99.8%	$513.4M+181899.1%	$282K-91.9%	$3.5M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

HCMC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

HCMC quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Gross Margin	-937.9%	-13234.5%	-27.6%-62.5pp	34.9%-4.8pp	39.7%-1.8pp	41.5%-1.4pp	42.9%-6.0pp	48.9%+0.5pp	48.4%-1.1pp	49.5%-9.1pp	58.6%+53.5pp	5.1%-32.2pp	37.3%-0.8pp	38.1%-19.8pp	57.9%
Operating Margin	-236084.2%	-1697351.3%	-1207716.2%	-29.6%+6.0pp	-35.6%-10.8pp	-24.8%+4.4pp	-29.2%-8.9pp	-20.4%+59.1pp	-79.5%+4.4pp	-83.9%	-429.3%	-83.2%-86.9pp	3.7%+14.5pp	-10.8%-17.8pp	7.1%
Net Margin	-235580.6%	N/A	-2995604.5%	-24.7%+5.6pp	-30.3%-3.6pp	-26.7%-8.2pp	-18.5%+71.4pp	-89.9%-13.6pp	-76.3%	101.1%	34.3%+124.9pp	-90.7%-93.7pp	3.1%+12.1pp	-9.0%-13.5pp	4.5%
Return on Equity	N/A	N/A	-273.5%-237.8pp	-35.7%-21.9pp	-13.8%+151.1pp	-164.9%-117.5pp	-47.4%+108.8pp	-156.2%+2066.4pp	-2222.6%-2648.5pp	426.0%	N/A	-1706.3%-1713.2pp	6.8%	N/A	51.4%
Return on Assets	-478.1%	N/A	-59.7%-46.6pp	-13.1%-1.3pp	-11.7%+19.6pp	-31.4%-11.4pp	-20.0%+66.8pp	-86.8%-2.4pp	-84.4%-146.4pp	62.0%+56.7pp	5.3%+286.3pp	-281.1%-286.8pp	5.7%+49.4pp	-43.7%-58.8pp	15.2%
Current Ratio	0.84+0.1x	0.73-0.2x	0.96-2.1x	3.06-8.3x	11.40+10.9x	0.53-0.5x	0.99-0.7x	1.69+0.9x	0.80-0.2x	0.97+0.3x	0.63-0.4x	1.03-5.2x	6.27+5.2x	1.08-0.3x	1.41
Debt-to-Equity	N/A	N/A	0.36+0.2x	0.12+0.1x	0.00-2.2x	2.18+0.8x	1.37+1.2x	0.17+0.1x	0.02-5.9x	5.89	N/A	5.07+4.9x	0.19	N/A	2.39
FCF Margin	N/A	-739084.6%	-797971.6%	-14.8%+12.1pp	-26.9%-10.3pp	-16.6%+7.0pp	-23.6%-22.1pp	-1.5%+21.4pp	-22.9%+46.6pp	-69.5%	-184.7%	-44.8%-28.9pp	-15.9%-11.1pp	-4.8%-6.6pp	1.8%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	N/A	N/A	N/A	100.0%	-2283.4%	17.0%	-42603.2%	71.2%
Operating Margin	N/A	N/A	N/A	-1047737.2%	-200361.0%	-121877.1%	-1404511.5%	-4121932.7%
Net Margin	N/A	N/A	N/A	-1043272.9%	-199179.7%	-122678.4%	N/A	-8359675.0%
Return on Assets	5.0%+59.9pp	-54.9%-2.6pp	-52.2%+83.9pp	-136.1%-6.6pp	-129.5%+1.0pp	-130.6%	N/A	-114.9%
Current Ratio	0.660.0x	0.62-0.2x	0.84+0.6x	0.27-0.1x	0.34-0.1x	0.45-0.3x	0.73-0.3x	1.06
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	-1040048.7%	842807.7%

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin, FCF Margin.

Note: Shareholder equity is negative (-$1.2M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.84), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Eco-Growth Strategies Inc ECGS

$5.1M

Charlie S Holdin CHUC

$67.3M

Green Globe GGII

$3.3M

Vpr Brands Lp VPRB

$8.8M

Medx Hldgs Inc MEDH

$1.5M

Where Healthier Choics Ranks

Frequently Asked Questions

What is Healthier Choics's annual revenue?

Healthier Choics (HCMC) reported $3K in total revenue for fiscal year 2025. This represents a 494.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Healthier Choics's revenue growing?

Healthier Choics (HCMC) revenue grew by 494.6% year-over-year, from $501 to $3K in fiscal year 2025.

Is Healthier Choics profitable?

No, Healthier Choics (HCMC) reported a net income of -$7.0M in fiscal year 2025.

What is Healthier Choics's EBITDA?

Healthier Choics (HCMC) had EBITDA of -$7.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Healthier Choics's operating cash flow?

Healthier Choics (HCMC) recorded an outflow of $3.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Healthier Choics's total assets?

Healthier Choics (HCMC) had $1.5M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Healthier Choics have outstanding?

Healthier Choics (HCMC) had 527.16B shares outstanding as of fiscal year 2025.

What is Healthier Choics's current ratio?

Healthier Choics (HCMC) had a current ratio of 0.84 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Healthier Choics's return on assets (ROA)?

Healthier Choics (HCMC) had a return on assets of -478.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

How does Healthier Choics's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, Healthier Choics (HCMC) held $1.1M in cash, cash equivalents and investments, and reported an operating cash outflow of $3.9M over that year. Dividing the one by the other, the reported balance equals about 4 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Why is Healthier Choics's debt-to-equity ratio negative or not reported?

Healthier Choics (HCMC) has negative shareholder equity of -$1.2M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Healthier Choics's Altman Z-Score?

Healthier Choics (HCMC) has an Altman Z-Score of -82.56, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Healthier Choics's Piotroski F-Score?

Healthier Choics (HCMC) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Healthier Choics's earnings high quality?

Healthier Choics (HCMC) reported a net loss of $7.0M while operations used $3.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Healthier Choics cover its interest payments?

Healthier Choics (HCMC) reported an operating loss of $7.0M against $35K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.